IRC
TMO icon

Investors Research Corp’s Thermo Fisher Scientific TMO Stock Holding History

Investors Research Corp’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1
Closed -$501 – 831
2026
Q2 		$501 Hold
1
– – ﹤0.01% 761
2026
Q1 		$492 Hold
1
– – ﹤0.01% 799
2025
Q4 		$579 Hold
1
– – ﹤0.01% 806
2025
Q3 		$485 Hold
1
– – ﹤0.01% 834
2025
Q2 		$405 Hold
1
– – ﹤0.01% 890
2025
Q1 		$498 Hold
1
– – ﹤0.01% 917
2024
Q4 		$520 Sell
1
-100
-99% -$55K ﹤0.01% 903
2024
Q3 		$62.5K Hold
101
– – 0.01% 460
2024
Q2 		$55.9K Hold
101
– – 0.01% 487
2024
Q1 		$58.7K Hold
101
– – 0.01% 486
2023
Q4 		$53.6K Hold
101
– – 0.01% 511
2023
Q3 		$51.1K Buy
101
+6
+6% +$3.2K 0.01% 510
2023
Q2 		$49.6K Hold
95
– – 0.01% 514
2023
Q1 		$54.8K Hold
95
– – 0.01% 517
2022
Q4 		$52.3K Hold
95
– – 0.01% 511
2022
Q3 		$48K Buy
95
+13
+16% +$7.28K 0.01% 506
2022
Q2 		$45K Buy
82
+75
+1,071% +$41.3K 0.01% 523
2022
Q1 		$4K Buy
+7
New +$4.02K ﹤0.01% 875
2020
Q4 		– Sell
-60
Closed -$26K – 1106
2020
Q3 		$26K Sell
60
-60
-50% -$24.8K 0.01% 627
2020
Q2 		$39K Buy
120
+60
+100% +$20.1K 0.02% 536
2020
Q1 		$17K Sell
60
-60
-50% -$18.9K 0.01% 659
2019
Q4 		$36K Buy
120
+60
+100% +$18.2K 0.02% 572
2019
Q3 		$17K Buy
60
+41
+216% +$11.7K 0.01% 745
2019
Q2 		$6K Hold
19
– – ﹤0.01% 866
2019
Q1 		$5K Buy
+19
New +$4.73K ﹤0.01% 867

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Investors Research Corp's TMO Position: Q3 2026 in Review

Investors Research Corp sold out of Thermo Fisher Scientific (TMO) in Q3 2026, closing a stake of 1 share — an estimated $501 sold.

Investors Research Corp first reported a position in TMO in Q1 2019 and held it in 25 quarters. The position peaked at $62.5K in Q3 2024. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Investors Research Corp reported no remaining Thermo Fisher Scientific position as of Q3 2026 after selling out during the quarter.
  • Investors Research Corp sold 1 Thermo Fisher Scientific share in Q3 2026, an estimated $501.
  • Investors Research Corp first reported a position in Thermo Fisher Scientific in Q1 2019 and held it in 25 quarters.
  • Investors Research Corp's Thermo Fisher Scientific position peaked at $62.5K in Q3 2024.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.